| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 7, 1158-1164, Copyright © 1996 by American Society of Nephrology
REGULAR ARTICLES |
LY Deng, R Day and EL Schiffrin
Medical Research Council Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreat, University of Montreal, Quebec, Canada.
Although the role of endothelin-1, a potent vasoconstrictor peptide, in hypertension remains unclear, there is evidence of its involvement in deoxycorticosterone acetate (DOCA)-salt hypertensive rats, in which enhanced vascular production of endothelin-1 has been documented. The study presented here examined endothelin-1 gene expression in the kidney in DOCA-salt hypertensive rats by in situ hybridization histochemistry. A high specific activity 35S-labeled complementary RNA probe was used. Significant increases in abundance of endothelin-1 mRNA transcripts were found in the endothelium of renal vessels, and in capillary endothelial and mesangial cells of glomeruli of the remaining kidney of DOCA-salt hypertensive rats, in comparison with unilaterally nephrectomized control rats. Enhanced expression of the endothelin-1 gene in the kidney of DOCA-salt hypertensive rats may participate in abnormalities of renal function in this model of hypertension, and thus contribute to the development and maintenance of elevated blood pressure.
This article has been cited by other articles:
![]() |
E. L. Schiffrin The Many Targets of Aldosterone Hypertension, May 1, 2004; 43(5): 938 - 940. [Full Text] [PDF] |
||||
![]() |
J. P. Granger Endothelin Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R298 - R301. [Full Text] [PDF] |
||||
![]() |
Q. Pu, M. F. Neves, A. Virdis, R. M. Touyz, and E. L. Schiffrin Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling Hypertension, July 1, 2003; 42(1): 49 - 55. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Amann, A. Simonaviciene, T. Medwedewa, A. Koch, S. Orth, M.-L. Gross, C. Haas, A. Kuhlmann, W. Linz, B. Scholkens, et al. Blood Pressure-Independent Additive Effects of Pharmacologic Blockade of the Renin-Angiotensin and Endothelin Systems on Progression in a Low-Renin Model of Renal Damage J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2572 - 2584. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-J. Hsieh, S.-R. Lin, Y.-J. Lee, S.-J. Shin, Y.-H. Lai, C.-H. Hsu, and J.-H. Tsai Increased renal medullary endothelin-1 synthesis in prehypertensive DOCA- and salt-treated rats Am J Physiol Renal Physiol, July 1, 2000; 279(1): F112 - F121. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ergul Hypertension in Black Patients : An Emerging Role of the Endothelin System in Salt-Sensitive Hypertension Hypertension, July 1, 2000; 36(1): 62 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Schiffrin Role of Endothelin-1 in Hypertension Hypertension, October 1, 1999; 34(4): 876 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ikeda, H. Ohta, M. Okada, N. Kawai, R. Nakao, P. K. S. Siegl, T. Kobayashi, S. Maeda, T. Miyauchi, and M. Nishikibe Pathophysiological Roles of Endothelin-1 in Dahl Salt-Sensitive Hypertension Hypertension, September 1, 1999; 34(3): 514 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Allcock, R. C. Venema, and D. M. Pollock ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R245 - R252. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673